Seagen upgraded by BMO Capital Markets with a new price target

10/11/22 7:47:53 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

BMO Capital Markets upgraded Seagen from Market Perform to Outperform and set a new price target of $178.00 from $177.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SGEN

Date	Price Target	Rating	Analyst
2/16/2023	$140.00 → $175.00	In-line → Outperform	Evercore ISI
2/16/2023	$155.00 → $175.00	Outperform → Strong Buy	Raymond James
2/6/2023	$162.00 → $141.00	Outperform → Market Perform	SVB Securities
11/21/2022	$135.00	Hold	Truist
10/11/2022	$177.00 → $178.00	Market Perform → Outperform	BMO Capital Markets
6/29/2022	$220.00	Outperform	Raymond James
6/24/2022	$169.00	Market Perform	BMO Capital Markets
2/16/2022	$201.00 → $142.00	Market Outperform	JMP Securities